ClinicalTrials.Veeva

Menu

Effects of Tracheostomy Decannulation on Respiratory Function

C

Capital Medical University

Status

Not yet enrolling

Conditions

Tracheostomy Decannulation

Treatments

Device: Speaking Valve ,Tracheostomy Tube Occlusion ,Tracheostomy Tube Ventilation

Study type

Observational

Funder types

Other

Identifiers

NCT07191509
2025-HXKFZX-FGN-01

Details and patient eligibility

About

This single-center prospective study enrolls adult patients with long-term tracheostomy who are ready for tube removal (decannulation). Twenty-four hours before decannulation, each participant will receive three physiologic tests-breathing through the tracheostomy tube, breathing with a one-way speaking valve, and breathing with the tube capped. Standard pulmonary-function and arterial-blood-gas measurements will be taken during each test and again 5 days after the tube is removed. The study compares these methods to identify which pre-decannulation test best predicts safe, successful decannulation and to describe the overall impact of tube removal on respiratory function.

Enrollment

120 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥ 18 years.
  • Tracheostomised patient whose primary illness is stable and who is scheduled for elective decannulation in the rehabilitation unit.
  • Able to tolerate a one-way speaking valve for ≥ 4 h on the day before planned decannulation.
  • Capable of following instructions and completing bedside spirometry.
  • Patient (or legally authorised representative) has provided written informed consent.

Exclusion criteria

  • No tracheostomy in place or requirement for re-intubation/re-cannulation after planned decannulation.
  • Inability to perform lung-function testing either via the tracheostomy tube or via the mouth/nose (e.g., severe upper-airway obstruction, facial deformity).
  • Unstable cardiopulmonary or neurological status that makes spirometry unsafe (e.g., ongoing myocardial ischemia, uncontrolled arrhythmia, severe agitation).
  • Any acute condition requiring isolation precautions that preclude study procedures.
  • Refusal or inability to sign informed consent.
  • Missing or incomplete key outcome data.

Trial contacts and locations

1

Loading...

Central trial contact

Jia Deng

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems